1. Manzano BR, Premoli AM, Santaella NG, Ikuta CRS, Rubira CMF, Santos PSDS. Sclerotherapy as an esthetic indication in oral vascular malformations: A case series. An Bras Dermatol. 2019;94:521-6.

https://doi.org/10.1016/j.abd.2019.09.010

PMid:31777351 PMCid:PMC6857549

2. Johann ACBR, Aguiar MCF, Carmo MAV, Gomez RS, Castro WH, Mesquita RA. Sclerotherapy of benign oral vascular lesion with ethanolamine oleate: An open clinical trial with 30 lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;100:579-84.

https://doi.org/10.1016/j.tripleo.2004.12.021

PMid:16243243 

3. Selim H, Selim A, Khachemoune A, Metwally SA. Use of sclerosing agent in the management of oral and perioral hemangiomas: Review and case reports. Med Sci Monit. 2007;13:114-9.

PMid:17767124

4. Haggstrom NA, Drolet BA, Baselga E, Chamlin SL, Garzon MC, Horii KA, et al. Prospective study of infantile hemangiomas: demographic, prenatal, and perinatal characteristics. J Pediatr. 2007;150:291-4.

https://doi.org/10.1016/j.jpeds.2006.12.003

PMid:17307549 

5. Kobayashi K, Nakao K, Kishishita S, Tamaruya N, Monobe H, Saito K, et al. Vascular malformations of the head and neck. Auris Nasus Larynx. 2013;40:89-92.

https://doi.org/10.1016/j.anl.2012.02.002

PMid:22534179 

6. Choi YH, Han MH, O-Ki K, Cha SH, Chang KH. Craniofacial cavernous venous malformations: percutaneous scleroterapy with use of ethanolamine oleate. J Vasc Interv Radiol. 2002;13:475-82.

https://doi.org/10.1016/S1051-0443(07)61527-9

PMid:11997355 

7. Clemens RK, Pfammatter T, Meier TO, Alomari AI, Amann-Vesti BR. Vascular malformations revisited. Vasa. 2015;44:5-22.

https://doi.org/10.1024/0301-1526/a000402

PMid:25537054 

8. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endotelial characteristics. Plastic Reconstr Surg. 1982;69:412-22.

https://doi.org/10.1097/00006534-198203000-00002

PMid:7063565 

9. Fowell C, Verea Linares C, Jones R, Nishikawa H, Monaghan A. Venous malformations of the head and neck: current concepts in management. Br J Oral Maxillofac Surg. 2017;55:3-9.

https://doi.org/10.1016/j.bjoms.2016.10.023

PMid:27894790 

10. Lazos JP, Piemonte ED, Panico RL. Oral Varix: a review. Gerodontology. 2015;32:82-9.

https://doi.org/10.1111/ger.12074

PMid:23992044 

11. Silva VA, Lima NL, Mesquita AT, da Silveira EM, Verli FD, de Miranda JL, et al. Intramuscular hemangioma in lip treated with sclerotherapy and surgery. Case Rep Dent. 2011;2011:302451.

https://doi.org/10.1155/2011/302451

PMid:22567433 PMCid:PMC3335477

12. Baer AH, Parmar HA, DiPietro MA, Kasten SJ, Mukherji SK. Hemangiomas and vascular malformations of the head and neck: A simplified approach. Neuroimaging Clin N Am. 2011;21:641-58.

https://doi.org/10.1016/j.nic.2011.05.007

PMid:21807316 

13. Sigaux N, Viremouneix L, Guibaud L, Breton P. Malformations veineuses superficielles cervico-faciales. Mise au point [Head and neck superficial venous malformations]. Rev Stomatol Chir Maxillofac Chir Orale. 2015;116:201-8.

https://doi.org/10.1016/j.revsto.2015.07.002

PMid:26296277 

14. Horbach SE, Lokhorst MM, Saeed P, De Goüyon Matignon De Pontouraude CM, Rothová A, van der Horst CM. Sclerotherapy for low-flow vascular malformations of the head and neck: A systematic review of sclerosing agents. J Plast J Plast Reconstr Aesthet Surg. 2016;69:295-304.

https://doi.org/10.1016/j.bjps.2015.10.045

PMid:26723834 

15. Fernandes DT, Elias RA, Santos-Silva AR, Vargas PA, Lopes MA. Benign oral vascular lesions treated by sclerotherapy with ethanolamine oleate: A retrospective study of 43 patients. Med Oral Patol Oral Cir Bucal. 2018;23:180-7.

https://doi.org/10.4317/medoral.22253

PMid:29476682 PMCid:PMC5911356

16. Hoque S, Das BK. Treatment of venous malformations with ethanolamine oleate: A descriptive study of 83 cases. Pediatr Surg Int. 2011;27:527-31.

https://doi.org/10.1007/s00383-010-2824-x

PMid:21290138 

17. Kato CN, Ribeiro MC, Abreu MH, Grossmann SD, Abreu LG, Caldeira PC, et al. What is the preferred concentration of ethanolamine oleate for sclerotherapyof oral vascular anomalies?. Med Oral Patol Oral Cir Bucal. 2020;25:468-73.

https://doi.org/10.4317/medoral.23448

PMid:32388528 PMCid:PMC7338073

18. da Silva WB, Ribeiro AL, Menezes SA, de Jesus Viana Pinheiro J, Alves-Junior S. Oral capillary hemangioma: A clinical protocol of diagnosis and treatment in adults. Oral Maxillofac Surg. 2014;18:431-7.

https://doi.org/10.1007/s10006-013-0436-z

PMid:24263242 

19. Correa PH, Nunes LC, Johann AC, Aguiar MC, Gomez RS, Mesquita RA. Prevalence of oral hemangioma, vascular malformation and varix in a Brazilian population. Braz Oral Res. 2007; 21:40-5.

https://doi.org/10.1590/S1806-83242007000100007

PMid:17384854 

20. Hassanein AH, Mulliken JB, Fishman SJ, Greene AK. Evaluation of terminology for vascular anomalies in current literature. Plast Reconstr Surg. 2011;127:347-51.

https://doi.org/10.1097/PRS.0b013e3181f95b83

PMid:21200229 

21. Zeevi I, Chaushu G, Alterman M, Chaushu L. Sclerotherapy of Vascular Malformations in the Oral Cavity-Minimizing Postoperative Morbidity. Medicina. 2020;56:254.

https://doi.org/10.3390/medicina56050254

PMid:32456057 PMCid:PMC7279465

22. Kato CNAO, Ribeiro MC, Amaral MBF, Grossmann SMC, Aguiar MCF, Mesquita RA. Experience with 5% ethanolamine oleate for sclerotherapy of oral vascular anomalies: a cohort of 15 consecutive patients. J Craniomaxillofac Surg. 2019;47:106-11.

https://doi.org/10.1016/j.jcms.2018.11.009

PMid:30527382 

23. Frieden IJ. Special symposium: management of hemangiomas. Pediatric Dermatol. 1997;14:57-83.

https://doi.org/10.1111/j.1525-1470.1997.tb00431.x

PMid:9050768 

24. Costa JR, Torriani MA, Hosni ES, D Ávila OP, Figueiredo PJ. Sclerotherapy for vascular malformations in the oral and maxillofacial region: treatment and follow-up of 66 lesions. J Oral Maxillofac Surg. 2011;69:88-92.

https://doi.org/10.1016/j.joms.2010.06.204

PMid:21272976 

25. Hiraoka K, Mota De Queiroz A, Aparecida Marinho S, Costa Pereira AA, Costa Hanemann JA. Sclerotherapy with monoethanolamine oleate in benign oral vascular lesions. Minerva Stomatol. 2012;61:31-6.

PMid:22274308

26. Hashizume M, Kitano S, Yamaga H, Sugimachi K. Haptoglobin to protect against renal damage from ethanolamine oleate sclerosant. Lancet. 1988;6:340-1.

https://doi.org/10.1016/S0140-6736(88)92400-2

PMid:2899760 

27. Matsumoto K, Nakanishi H, Koizumi Y, Seike T, Kanda I, Kubo Y. Sclerotherapy of hemangioma with late involution. Dermatol Surg. 2003;29:668-71.

https://doi.org/10.1046/j.1524-4725.2003.29159.x

PMid:12786717 

28. Mariano FV, Vargas PA, Coletta RD, Lopes MA. Sclerotherapy followed by surgery for the treatment of oral hemangioma: A report of two cases. Gen Dent. 2011;59:121-5.

PMid:21903533

29. Kim KH, Sung MW, Roh JL, Han MH. Sclerotherapy for congenital lesions in the head and neck. Otolaryngol Head Neck Surg. 2004;131:307-16.

https://doi.org/10.1016/j.otohns.2004.02.018

PMid:15365552 

30. Hayashi N, Masumoto T, Okubo T, Abe O, Kaji N, Toquiota K, et al. Hemangiomas in the face and extremities: MR-guided sclerotherapy-Optimization with monitoring of signal intensity changes in vivo. Radiology. 2003;226:567-72.

https://doi.org/10.1148/radiol.2262012157

PMid:12563156